Wolfe Research Downgrades ONEOK to Underperform

Wolfe Research analyst Alex Kania downgrades ONEOK (NYSE:OKE) from Peer Perform to Underperform.

byBenzinga Newsdesk

January 10, 2022

1 minute read

Wolfe Research analyst Alex Kania downgrades ONEOK (NYSE:OKE) from Peer Perform to Underperform.

What’s Going On With Nvidia Stock Today?

By Adam Eckert

November 8, 9:28 AM

NVIDIA Corp (NASDAQ: NVDA) shares are trading higher Tuesday following reports the company will offer a new advanced chip in China that meets rec

NVDA

Merck and Ridgeback Announce U.S. Government To Purchase 1.4M Additional Courses Of Molnupiravir, An Investigational Oral Antiviral Medicine, For Treatment Of Mild-To-Moderate COVID-19 For ~$1B

By Bill Haddad

November 9, 7:14 AM

Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United States government will exercise two of its options to purchase a total of 1.4 million

MRK

Merck & Co Q3 EPS $1.75 Beats $1.55 Estimate, Sales $13.20B Beat $12.33B Estimate

By Benzinga Newsdesk

October 28, 6:31 AM

Merck & Co (NYSE:MRK) reported quarterly earnings of $1.75 per share which beat the analyst consensus estimate of $1.55 by 12.9 percent. This is a 0.57 percent increase over earnings of $1.74 per share from the same

MRK